NewGenIvf Group EBIT

NewGenIvf Group (NIVF) currently reports a EBIT of $9.6M as of December 2025. That compares with $-2.5M in the prior-year period — up 481.4% year over year. That is above the sector sector average of $-6.4M. Use the charts on this page to explore NewGenIvf Group's EBIT history and peer comparisons.

NewGenIvf Group's EBIT increased from $-2.5M to $9.6M — a 481.4% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NewGenIvf Group's EBIT of $9.6M is higher than the its sector sector average of $-6.4M. That is roughly 250.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

NewGenIvf Group reported $9.6M in EBIT as of December 2025. That compares with $-2.5M in the prior-year period — up 481.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $9.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for NewGenIvf Group, and consider following NIVF for alerts when major investors trade the stock.